Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas

Journal of Endocrinological Investigation

Volumn 32, Issue 5, 2009, Pages 460-464

  Cozzi, R ^a   Lasio, G ^b   Cardia, A ^b   Felisati, G ^c   Montini, M ^d   Attanasio, R ^b,d  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Endoscopic neurosurgery; Hypocortisolism; Perioperative treatment; Pituitary adenoma; Pituitary function

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSSPHENOIDAL ADENOMECTOMY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PITUITARY-ADRENAL SYSTEM; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; YOUNG ADULT;

EID: 70350340071     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.3275/6237     Document Type: Article

References (43)

1. Kovacs K, Horvath E, Vidal S. Classification of pituitary adenomas. J Neurooncol 2001, 54: 121-127
2. Kontogeorgos G. Classification and pathology of pituitary tumors. Endocrine 2005, 28: 27-35.
3. Karavitaki N, Collison K, Halliday J, et al. What is the natural history of non operated non functioning pituitary adenomas? Clin Endocrinol 2007, 67: 938-943
4. Jho HD. Endoscopic transsphenoidal surgery. J Neurooncol 2001, 54: 187-195
5. Nasseri SS, Kasperbauer JL, Strome SE, McCaffrey TV, Atkinson JL, Meyer FB. Endoscopic transnasal pituitary surgery: report on 180 cases. Am J Rhinol 2001, 15: 281-287 (Pubitemid 33695071)
6. Har-El G. Endoscopic transnasal transsphenoidal pituitary surgery- comparison with the traditional sublabial transseptal approach. Otolaryngol Clin N Amer 2005, 38: 723-735 (Pubitemid 40991314)
7. Rudnik A, Zawadzki T, Gatuszka-Ignasiak B, et al. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas - first experience. Minim Invas Neurosurg 2006, 49: 10-14
8. Koc K, Anik I, Ozdamar D, Cabuk B, Keskin G, Ceylan S. The learning curve in endoscopic pituitary surgery and our experience. Neurosurg Rev 2006, 29: 298-305. (Pubitemid 44379658)
9. Dusick JR, Esposito F, Mattozo CA, Chaloner C, McArthur DL, Kelly DF. Endonasal transsphenoidal surgery: the patient's perspective- survey results from 259 patients. Surg Neurol 2006, 65: 332-341 (Pubitemid 43384073)
10. Shah S, Har-EI G. Diabetes insipidus after pituitary surgery: incidence after traditional versus endoscopic transsphenoidal approaches. Am J Rhinol 2001, 15: 377-379 (Pubitemid 34026923)
11. Nemergut EC, Dumont AS, Barry UT, Laws ER. Perioperative management of patients undergoing transsphenoidal pituitary surgery. Anesth Analg 2005, 101: 1170-1181 (Pubitemid 41383093)
12. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994, 219: 416-425 (Pubitemid 24121456)
13. Lasio G, Ferroli P, Felisati G, Broggi G. Image-guided endoscopic transnasal removal of recurrent pituitary adenomas. Neurosurgery 2002, 51: 132-137 (Pubitemid 36331108)
14. Flynn BC, Nemergut EC. Postoperative nausea and vomiting and pain after transsphenoidal surgery: a review of 877 patients. Anest Analg 2006, 103: 162-167 (Pubitemid 44036052)
15. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the CS space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993, 33: 610-618 (Pubitemid 23292752)
16. Giordano R, Picu A, Bonelli L, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol (Oxf) 2008, 68: 935-941 (Pubitemid 351703953)
17. Tomlinson JW, Holden N, Hills RK, et al. Association between pre- mature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001, 357: 425-431 (Pubitemid 32156141)
18. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - a study on 721 patients. Acta Neurochir (Wien) 2004, 146: 27-35. (Pubitemid 38186204)
19. Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf) 2005, 63: 499-505. (Pubitemid 41626743)
20. van Aken MO, Lamberts SWJ. Diagnosis and treatment of hypopituitarism: an update. Pituitary 2005, 8: 183-191
21. Arafah BM, Kailani SH, Nekl KE, Gold RS, Selman WR. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 1994, 79: 348-354
22. Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002, 87: 2745-2750
23. Dökmetas HS, Çolak R, Kelestimur F, Selçuklu A, Ünlühizarci K, Bayram F. A comparison between the 1-μg adrenocorticotropin (ACTH) test, the short ACTH (250 μg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000, 85: 3713-3719 (Pubitemid 30828581)
24. Hout WM, Arafah BM, Salazar R, Selman W. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary? J Clin Endocrinol Metab 1988, 66: 1208-1212
25. Garcia-Luna PP, Leal-Cerro A, Rocha JL, Trujillo F, Garcia-Pesquera F, Astorga R. Evaluation of the pituitary-adrenal axis before, during and after pituitary adenomectomy: is perioperative glucocorticoid therapy necessary? Acta Endocrinol (Copenh) 1990, 122: 83-88
26. Auchus RJ, Shewbridge RK, Shepherd MD. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery? Clin Endocrinol (Oxf) 1997, 46: 21-27
27. Rajaratnam S, Seshadri MS, Chandy MJ, Rajshekhar V. Hydrocortisone dose and postoperative diabetes insipidus in patients undergoing transsphenoidal pituitary surgery: a prospective randomized controlled study. Br J Neurosurg 2003, 17: 437-442 (Pubitemid 37421569)
28. Smith M, Hirsch NP. Pituitary disease and anaesthesia. Br J Anaesth 2000, 85: 3-14.
29. Courtney CH, McAllister AS, Bell PM, et al. Low- and standard- dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgery. J Clin Endocrinol Metab 2004, 89: 1712-1717
30. Wentworth JM, Gao N, Sumithran KP, et al. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary. Clin Endocrinol 2008, 68: 29-35. (Pubitemid 350243478)
31. Abdu TAM, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short Synacthen test (1 μg), the conventional dose short Synacthen test (250 mu;g), and the insulin tolerance test for assessment of the hypothalamo- pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999, 84: 838-843 (Pubitemid 29138205)
32. Pfeifer M, Kanc K, Verhovec R, Kocijancic A. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men. Clin Endocrinol (Oxf) 2001, 54: 17-22. (Pubitemid 32158700)
33. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol levels, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991, 72: 773-778 (Pubitemid 21921764)
34. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995, 80: 1301-1315
35. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996, 44: 151-156 (Pubitemid 26042968)
36. Thaler LM, Blevins LS. The low dose (1-μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 1998, 83: 2726-2729
37. Ambrosi B, Barbetta L, Re T, Passini E, Faglia G. The one microgram adrenocorticotropin test in the assessment of hypothalamic- pituitary-adrenal function. Eur J Endocrinol 1998, 139: 575-579 (Pubitemid 29030392)
38. Gandhi PG, Shah NS, Khandelwal AG, Chauhan P, Menon PS. Evaluation of low dose ACTH stimulation test in suspected secondary adrenocortical insufficiency. J Postgrad Med 2002, 48: 280-282 (Pubitemid 36305510)
39. Magnotti M, Shimshi M. Diagnosing Adrenal Insufficiency: Which Test is Best: The 1-μg or the 250-mu;g Cosyntropin Stimulation Test? Endocr Pract 2008, 14: 233-238
40. Dorin RI, Quails CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Int Med 2003, 139: 194-204.
41. Gonzalbez J, Villabona C, Ramoa J, et al. Establishment of reference values for standard dose short synacthen test (250 mu;g), low dose short synacthen test (1 mu;g) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol 2000, 53: 199-204.
42. Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long- term predictive accuracy of the short Synacthen (Corticotropin) stimulation test for assessment of the hypothalamic-pituitary- adrenal axis. J Clin Endocrinol Metab 2006, 91: 43-47 (Pubitemid 43069115)
43. Oelkers W. Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adreno- corticotropin test. Eur J Endocrinol 1996, 135: 27-33. (Pubitemid 26232701)